AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 173 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $969,000 | -87.8% | 73,141 | -83.0% | 0.01% | -88.0% |
| Q3 2017 | $7,960,000 | -45.9% | 431,411 | -46.1% | 0.12% | -43.2% |
| Q2 2017 | $14,721,000 | -3.8% | 800,055 | +17.8% | 0.21% | +6.2% |
| Q1 2017 | $15,310,000 | -26.7% | 678,918 | +13.0% | 0.19% | -27.9% |
| Q4 2016 | $20,900,000 | +67.9% | 600,584 | +18.3% | 0.27% | +66.0% |
| Q3 2016 | $12,446,000 | +26.3% | 507,809 | +23.3% | 0.16% | +37.3% |
| Q2 2016 | $9,853,000 | +106.2% | 411,912 | +101.7% | 0.12% | +118.5% |
| Q1 2016 | $4,778,000 | -26.9% | 204,184 | -5.7% | 0.05% | -23.9% |
| Q4 2015 | $6,535,000 | -83.5% | 216,456 | -78.3% | 0.07% | -81.6% |
| Q3 2015 | $39,593,000 | +12.3% | 996,545 | +95.2% | 0.39% | +30.8% |
| Q2 2015 | $35,262,000 | – | 510,597 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
| Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
| Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
| FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
| EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
| CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
| Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
| Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
| Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |